Font Size: a A A

The Meta-analysis Of The Prognosis Of Hepatocellular Carcinomapatients With Portal Vein Tumor Thrombus Treatment With Transcatheter Arterial Chemoembolization

Posted on:2015-02-01Degree:MasterType:Thesis
Country:ChinaCandidate:M Y HuFull Text:PDF
GTID:2284330434454776Subject:Surgery
Abstract/Summary:PDF Full Text Request
Objective:Application of Meta-analysis to evaluate the patients ofhepatocellular carcinoma (Hepatocellular Carcinoma, HCC) with portalvein tumor thrombosis (Portal Vein Tumor Thrombosis,PVTT) with theclinical efficacy of TACE, to guide the clinical work.Methods:Two reviewers searched PubMed(1966to Jan.2014),EMbase(1974to Jan.2014), CBM(1979to Jan.2014), CNKI(1979toJan.2014) and VIP (1989to Jan.2014) by computer. Two authors identifiedstudies which of hepatocellular carcinoma patients with portal vein tumorthrombus underwent transcatheter arterial chemoembolization.Two authorsinternalized randomized controlled trial(Randomized ControlledTrial,RCT)、controlled clinical trial(Controlled Clinical Trial,CCT) andcohort study in Chinese and English which met the inclusion criterion,extracted data and evaluated the literatures quality. We integrated andanalyze the extracted data by software Review Manager5.2.Results: Retrieved9literatures met the inclusion criteria, involved 1068patients, of which6is RCT,3is CCT.9literatures for hepatocellularcarcinoma with portal vein tumor thrombus underwent TACE comparedwith the conservative treatment.The results showed that: compared to theTACE treatment and conservative treatment:TACE can significantlyimprove the hepatocellular carcinoma with portal vein tumor thrombus inthe half year survival rate of [OR=4.92,95%CI (2.73,8.86)](P<0.0001),1year survival rate of [OR=10.73,95%CI (3.12,36.95)](P<0.0001),2yearsurvival rate of [OR=25.45,95%CI (8.00,80.99)](P<0.0001).For thedifferent type of PVTT,, the type I gets better benefit from TACE than typeII and III, type II is better than type III,the effect of type IV is the worst.Conclusion: Hepatocellular carcinoma with portal vein tumorthrombus in patients with transcatheter arterial chemoembolization forconservative treatment can significantly increase the survival rate ofpatients.For the different type of PVTT,, the type I gets better benefit fromTACE than type II and III, type II is better than type III,the effect of typeIV is the worst.
Keywords/Search Tags:hepatocellular carcinoma, portal vein tumor thrombus, Transcatheterhepatic arterial chemoembolization, Meta-analysis
PDF Full Text Request
Related items
Meta-analysis Of Clinical Efficacy Of Tace Combined With 125I Radioactive Particles In Patients With Hepatocellular Carcinoma Complicated With Portal Vein Tumor Thrombus
Surgical Resection Plus Transcatheter Arterial Chemoembolization For Patients With Hepatocellular Carcinoma (HCC) And Concomitant Portal Vein Tumor Thrombus(PVTT):an Analysis Of Therapeutic Efficacy
The Efficacy Of Transcatheter Arterial Chemoembolization Combined With Radiation Therapy Versus Transcatheter Arterial Chemoembolization For Hepatocellular Carcinoma With Portal Vein Tumor Thrombus:a Meta-analysis
Meta-analysis Of Surgical Resection And Transcatheter Arterial Chemoembolization In The Treatment Of Hepatocellular Carcinoma Complicated With Portal Vein Tumor Thrombus
Therapeutic Effect Of Transcatheter Arterial Chemoembolization Combined With Portal Vein 125I Particle Implantation And Stent Implantation In Treatment Of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Endovascular Implantation Of Iodine-125 Seeds Strand And Portal Vein Stenting Followed By Transcatheter Arterial Chemoembolization Combined Therapy With Sorafenib For Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombus
Inical Research Of Tace With3-dcrt To Treat Primary Hepatic Carcinoma With Portal Vein Tumor Thrombus
Analysis Of Curative Effects Of The Treatment Of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Survival Prognosis Of Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombus After Adjuvant Hepatic Transcatheter Arterial Chemoembolization Combined With Portal Vein Chemotherapy
10 Retrospective Study Of Clinical Efficacy Of TACE Combined With Endovascular Treatment Of Portal Vein Of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus